Miles, Lachlan F.
Richards, Toby
Funding for this research was provided by:
University of Melbourne
Article History
Accepted: 8 November 2021
First Online: 19 January 2022
Declarations
:
: Lachlan F. Miles is the Coordinating Principal Investigator on a currently running prospective study that has received funds from Vifor Pharma as part of a matched funding arrangement with the Victorian Government. Toby Richards has received grants, personal fees, and non-financial support from Pharmocosmos and Vifor Pharma. He was also the Coordinating Principal Investigator of the PREVENTT trial, discussed extensively in this article, and has also received speaker’s honoraria from Medtronic. Professor Richards is also a regular speaker at national and international conferences on anemia, blood transfusion, wound healing, and vascular diseases for which he has received expenses for travel, accommodation, and sundries. He has worked with several agencies promoting meetings or healthcare, and is a director of The Iron Clinic Ltd and director of Veincare London Ltd, and is also the Vascular Lead for 18-week Wait Ltd.
: This article does not contain any studies with human or animal subjects performed by any of the authors.